NCT05523115

Brief Summary

The Smart Supplement has 20 vitamins and minerals that have strong track records of demonstrating positive health effects, both physiologically and cognitively. This twelve-week trial will examine the effectiveness and efficacy of Heights Smart Supplement on both biomarkers and subjective experiences from participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 31, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

4 months

First QC Date

August 26, 2022

Last Update Submit

November 7, 2022

Conditions

Keywords

memorystressanxietymoodfocus

Outcome Measures

Primary Outcomes (3)

  • Changes in Measures of C-reactive protein

    Biomarkers measured by a third party lab through blood samples submitted by participants.

    12 weeks

  • Changes in Measures of cortisol

    Biomarkers measured by a third party lab through blood samples submitted by participants.

    12 weeks

  • Changes in Sleep Quality as measured via Fitness trackers and Questionnaires

    Measurements taken via existing smart watches and report that data on the questionnaires.

    12 weeks

Secondary Outcomes (1)

  • examine the subjective experiences of participants taking the Heights Smart Supplement.

    12 weeks

Study Arms (1)

Heights Smart Supplement

EXPERIMENTAL

Participants will take the supplement over a 12 week period. There will be both biomarker outcomes and subjective outcomes reported by the participants via questionnaires.

Dietary Supplement: Heights Smart Supplement

Interventions

Heights Smart SupplementDIETARY_SUPPLEMENT

The ingredient list of the product includes the following: Algae oil Blueberry Extract Methylcobalamin (Vitamin B12) Cholecalciferol (Vitamin D3) Ascorbic acid (Vitamin C) Retinol acetate (Vitamin A) Calcium L-methylfolate (Folic Acid) D-biotin Pyridoxine hydrochloride (Vitamin B6) Calcium pantothenate (Vitamin B5) Nicotinamide (Vitamin B3) Riboflavin (Vitamin B2) Thiamine hydrochloride (Vitamin B1) D-Alpha tocopheryl acetate (Vitamin E) Chromium picolinate Potassium iodide Iron Citrate Sodium selenite Zinc citrate

Heights Smart Supplement

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In good general health with no major chronic conditions
  • Must experience one of the following issues: brain fog
  • OR issues with fatigue,
  • OR sleep issues,
  • OR trouble with focus and concentration,
  • OR lead a busy, stressful life.
  • Must have a fitness tracker that they use to track sleep behaviors.
  • May be on a vegan/vegetarian diet

You may not qualify if:

  • Females who are pregnant or breastfeeding
  • Anyone currently taking other supplements focused on brain health, or multi vitamins, including additional iron supplements
  • Anyone taking Thyroxine and Levothyroxine
  • Anyone taking antidepressants (such as Sertraline or SSRIs like fluoxetine)
  • Anyone on hormone replacement therapy
  • Anyone taking blood pressure medication (such as linosipril)
  • Anyone with a known allergic reaction
  • Any chronic conditions, including oncological and psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Anxiety DisordersMemory DisordersACTH Syndrome, Ectopic

Condition Hierarchy (Ancestors)

Mental DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsParaneoplastic Endocrine SyndromesParaneoplastic SyndromesNeoplasms

Study Officials

  • Christopher Hill, PhD

    Citruslabs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2022

First Posted

August 31, 2022

Study Start

June 15, 2022

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

November 8, 2022

Record last verified: 2022-11

Locations